Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,355 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,367)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04638751 | ARGONAUT: Stool and Blood Sample Bank for Cancer Patients | suspended | — | 5,000 | Persephone BiosciencesINDUSTRY | 1 | Sep 18, 2026 | clinicaltrials |
| NCT05378464 | Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer | suspended | Phase 1 | 28 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 15, 2026 |
| clinicaltrials |
| NCT03077841 | Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer | suspended | Phase 2 / Phase 3 | 928 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 14, 2026 | clinicaltrials |
| NCT06671912 | Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial(LoTam) | suspended | Phase 3 | 1,556 | Alliance for Clinical Trials in OncologyOTHER | 2 | Sep 2, 2026 | clinicaltrials |
| NCT02993068 | Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible) | suspended | N/A | 5,200 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT04803084 | Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment | suspended | — | 10 | Laura KennedyOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT07102212 | Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS)(FOCUS) | suspended | N/A | 120 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT03987555 | Paclitaxel Therapeutic Drug Monitoring in Cancer Patients | suspended | — | 55 | Wake Forest University Health SciencesOTHER | 1 | Aug 13, 2026 | clinicaltrials |
| NCT05673200 | Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer | suspended | Phase 1 | 32 | National Cancer Institute (NCI)NIH | 1 | Jul 31, 2026 | clinicaltrials |
| NCT06060561 | Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy | suspended | — | 500 | Mayo ClinicOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT06538389 | High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer | suspended | Phase 2 | 36 | City of Hope Medical CenterOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT05967533 | The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors | suspended | Phase 1 | 100 | University of California, DavisOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT05315011 | Assessment of Cryotherapy's Analgesic Impact in Anti-aromatase-induced Arthralgia(CRYOMATASE) | suspended | N/A | 70 | University Hospital, MontpellierOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT04906369 | Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring | suspended | — | 150 | Mayo ClinicOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT06214793 | Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) | suspended | Phase 2 | 61 | Megan Kruse, MDOTHER | 1 | Jun 5, 2026 | clinicaltrials |
| NCT04955808 | Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery | suspended | — | 2,400 | National Cancer Institute (NCI)NIH | 1 | May 13, 2026 | clinicaltrials |
| NCT04541381 | The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care | suspended | N/A | 860 | University of ChicagoOTHER | 1 | May 7, 2026 | clinicaltrials |
| NCT03838419 | Intraoperative Electron Radiotherapy for Low-risk Early Breast Cancer(COSMOPOLITAN) | suspended | N/A | 101 | University Hospital HeidelbergOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT07140965 | The Impact of Surgeon-Interpreted Intraoperative Margin Assessment During Breast Conserving Surgery on Postoperative Treatment | suspended | — | 175 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT05547347 | Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer | suspended | — | 15 | Mayo ClinicOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT07178665 | Pilot Trial of Preop Partial Radiation in Breast Cancer Patients | suspended | Phase 1 | 98 | Rutgers, The State University of New JerseyOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT04973930 | Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer(IPT) | suspended | Phase 3 | 20 | New York State Psychiatric InstituteOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT04339517 | Postoperative Identification of Tumor Cells At the Lumpectomy Site of Patients with Early Breast Cancer | suspended | N/A | 20 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT04151368 | Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing Mastectomy(RNSM) | suspended | N/A | 30 | University Health Network, TorontoOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT05076591 | IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors | suspended | Phase 1 | 135 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc.OTHER | 1 | Oct 30, 2024 | clinicaltrials |
| NCT02037529 | Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer | suspended | Phase 3 | 201 | Academic and Community Cancer Research UnitedOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT04946864 | A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer | suspended | Phase 1 / Phase 2 | 65 | Ascentage Pharma Group Inc.INDUSTRY | 2 | Aug 19, 2024 | clinicaltrials |
| NCT04120246 | Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer | suspended | Phase 1 | 24 | Veana TherapeuticsINDUSTRY | 1 | Jul 10, 2024 | clinicaltrials |
| NCT04619186 | Diffusion-Weighted MRI for Breast Cancer Screening in Women With a Personal History of Breast Cancer | suspended | — | 1,694 | Seoul National University HospitalOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT04714983 | DNX-2440 for Resectable Colorectal Liver Metastasis | suspended | Phase 1 | 30 | DNAtrix, Inc.INDUSTRY | 1 | Apr 9, 2024 | clinicaltrials |
| NCT03002103 | A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer | suspended | Phase 3 | 420 | SynCore Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 26, 2023 | clinicaltrials |
| NCT04650451 | Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors | suspended | Phase 1 | 220 | Bellicum PharmaceuticalsINDUSTRY | 1 | Apr 20, 2023 | clinicaltrials |
| NCT05506800 | Guangzhou Women's Health Cohort Study (GWHCS) | suspended | — | 1,000,000 | Guangzhou Women and Children's Medical CenterOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT04116281 | Short and Long Term Effects of a Physical Therapy Program After Breast Cancer Surgery | suspended | N/A | 36 | Universidade Federal de Sao CarlosOTHER | 1 | Jul 12, 2022 | clinicaltrials |
| NCT02897050 | Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer | suspended | Phase 2 | 170 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Apr 20, 2022 | clinicaltrials |
| NCT04683120 | Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics | suspended | N/A | 100 | Laser LabCorpINDUSTRY | 1 | Jun 30, 2021 | clinicaltrials |
| NCT04250818 | Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile | suspended | — | 20 | Texas Tech University Health Sciences Center, El PasoOTHER | 1 | May 19, 2021 | clinicaltrials |
| NCT00738777 | Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer | suspended | Phase 2 | 250 | The Netherlands Cancer InstituteOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT04474652 | Guide for Prioritisation of Patients for Referral to Breast Clinics | suspended | — | 4,000 | The Leeds Teaching Hospitals NHS TrustOTHER | 1 | Jul 17, 2020 | clinicaltrials |
| NCT03845907 | Clinical Evaluation of Opto-Acoustic Image Quality With the Gen1B Duplex Probe in Breast Applications | suspended | N/A | 4 | Seno Medical Instruments Inc.INDUSTRY | 1 | Apr 6, 2020 | clinicaltrials |
| NCT03777579 | A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC | suspended | Phase 3 | 375 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Aug 8, 2019 | clinicaltrials |
| NCT02313116 | Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B) | suspended | — | 50 | Diagnostic Photonics, Inc.INDUSTRY | 1 | Jul 18, 2019 | clinicaltrials |
| NCT03271853 | Thermalogical Analysis of a Cohort of Women and Men Undergoing Mammographic Analysis. | suspended | — | 2,000 | First Sense Medical, LLCOTHER | 1 | Jan 10, 2018 | clinicaltrials |
| NCT00673829 | Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer | suspended | Phase 1 | 26 | Roger Williams Medical CenterOTHER | 1 | Jun 17, 2016 | clinicaltrials |
| NCT02062983 | Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients | suspended | — | 50 | National Guard Health AffairsOTHER_GOV | 1 | May 13, 2016 | clinicaltrials |
| NCT00002696 | Combination Chemotherapy in Treating Women With Stage III Breast Cancer | suspended | Phase 3 | — | Grupo Oncologico Cooperativo del SurOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00909558 | Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer | suspended | Phase 1 | 24 | Envita Medical Center, Inc.INDUSTRY | 1 | Feb 24, 2010 | clinicaltrials |
| NCT00637364 | High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain(HIFU Pancreas) | suspended | Phase 1 / Phase 2 | 5 | CMED HIFU Development CorporationINDUSTRY | 1 | Jan 13, 2009 | clinicaltrials |
Data updated 11 days agoSource updated Sep 18, 2026source: clinicaltrials